ETR:AFX Carl Zeiss Meditec (AFX) Stock Price, News & Analysis → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Free AFX Stock Alerts €115.80 -3.60 (-3.02%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range€115.80▼€119.7050-Day Range€98.00▼€121.9552-Week Range€72.60▼€136.40Volume104,111 shsAverage Volume94,405 shsMarket Capitalization$10.36 billionP/E Ratio37.35Dividend Yield0.95%Price Target€175.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesStock AnalysisAnalyst ForecastsChartHeadlines Get Carl Zeiss Meditec alerts: Email Address Carl Zeiss Meditec MarketRank™ Stock AnalysisAnalyst Rating0.00 Rating ScoreUpside/Downside51.1% Upside€175.00 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.87Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.12 out of 5 stars 2.0 Analyst's Opinion Price Target Upside/DownsideAccording to analysts' consensus price target of €175.00, Carl Zeiss Meditec has a forecasted upside of 51.1% from its current price of €115.80.Amount of Analyst CoverageCarl Zeiss Meditec has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for AFX. Previous Next 0.8 Dividend Strength Dividend YieldCarl Zeiss Meditec has a dividend yield of 0.94%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCarl Zeiss Meditec does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Carl Zeiss Meditec is 35.48%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AFX. Previous Next 2.7 News and Social Media Coverage News SentimentCarl Zeiss Meditec has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Carl Zeiss Meditec this week, compared to 0 articles on an average week.MarketBeat FollowsOnly 1 people have added Carl Zeiss Meditec to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Carl Zeiss Meditec insiders have not sold or bought any company stock.Percentage Held by Insiders59.14% of the stock of Carl Zeiss Meditec is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 24.71% of the stock of Carl Zeiss Meditec is held by institutions. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Carl Zeiss Meditec is 37.35, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 146.90.Price to Earnings Ratio vs. SectorThe P/E ratio of Carl Zeiss Meditec is 37.35, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 270.19.Price to Earnings Growth RatioCarl Zeiss Meditec has a PEG Ratio of 4.30. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCarl Zeiss Meditec has a P/B Ratio of 4.80. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the Markets[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>> About Carl Zeiss Meditec Stock (ETR:AFX)Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.Read More AFX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AFX Stock News HeadlinesMarch 28, 2024 | msn.comReachTV Names First-Ever President Bob Gruters; Hires Andrew Eisner As EVP Sales & PartnershipsMarch 28, 2024 | finanznachrichten.deCarl Zeiss Meditec AG: ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024March 29, 2024 | Behind the Markets (Ad)[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.March 28, 2024 | finance.yahoo.comZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024March 16, 2024 | barrons.comCarl Zeiss Meditec AGFebruary 20, 2024 | au.finance.yahoo.comCarl Zeiss Meditec AG (AFX.DE)February 4, 2024 | au.finance.yahoo.comCarl Zeiss Meditec AG (AFX.SW)February 2, 2024 | uk.investing.comCarl Zeiss Meditec AG ADR (CZMWY)March 29, 2024 | Behind the Markets (Ad)[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.December 11, 2023 | finance.yahoo.comThe Return Trends At Carl Zeiss Meditec (ETR:AFX) Look PromisingOctober 28, 2023 | morningstar.comCarl Zeiss Meditec AG AFXOctober 17, 2023 | finance.yahoo.comThe past three years for Carl Zeiss Meditec (ETR:AFX) investors has not been profitableOctober 2, 2023 | finanznachrichten.deCarl Zeiss Meditec AG: ZEISS and Boehringer Ingelheim join forces to develop early detection of eye diseases and prevent vision lossSeptember 22, 2023 | finance.yahoo.comCarl Zeiss Meditec AG's (ETR:AFX) 4.0% loss last week hit both individual investors who own 59% as well as institutionsJuly 18, 2023 | finance.yahoo.comDo Carl Zeiss Meditec's (ETR:AFX) Earnings Warrant Your Attention?July 15, 2023 | uk.finance.yahoo.comAFX.DE - Carl Zeiss Meditec AGMay 10, 2023 | markets.businessinsider.comCarl Zeiss Meditec H1 Profit Down, Revenues Rise; Backs FY23 Outlook - Quick FactsMay 10, 2023 | markets.businessinsider.comEQS-News: Carl Zeiss Meditec achieves double-digit growth in first half year of 2022/23 with declining earningsMay 10, 2023 | finance.yahoo.comCarl Zeiss Meditec (ETR:AFX) sheds 8.7% this week, as yearly returns fall more in line with earnings growthMarch 29, 2023 | finance.yahoo.comDoes This Valuation Of Carl Zeiss Meditec AG (ETR:AFX) Imply Investors Are Overpaying?February 4, 2023 | finance.yahoo.comWith EPS Growth And More, Carl Zeiss Meditec (ETR:AFX) Makes An Interesting CaseDecember 29, 2022 | finance.yahoo.comCarl Zeiss Meditec (ETR:AFX) Is Paying Out A Larger Dividend Than Last YearDecember 1, 2022 | finance.yahoo.comCarl Zeiss Meditec's (ETR:AFX) five-year total shareholder returns outpace the underlying earnings growthNovember 17, 2022 | finance.yahoo.comWhen Should You Buy Carl Zeiss Meditec AG (ETR:AFX)?November 1, 2022 | finance.yahoo.comPrivate companies who hold 59% of Carl Zeiss Meditec AG (ETR:AFX) gained 4.3%, institutions profited as wellAugust 31, 2022 | finanznachrichten.deCarl Zeiss Meditec AG: ZEISS Integrated Workflow Solutions are Creating the Digital Transformation in HealthcareAugust 5, 2022 | nasdaq.comCarl Zeiss Meditec 9-month Operating Result Slightly DeclinesSee More Headlines Receive AFX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeETR SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolETR:AFX CUSIPN/A CIKN/A Webwww.zeiss.com Phone+49-3641-2200FaxN/AEmployees4,823Year FoundedN/APrice Target and Rating Average Stock Price Target€175.00 High Stock Price Target€175.00 Low Stock Price Target€175.00 Potential Upside/Downside+46.6%Consensus Rating Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)€3.10 Trailing P/E Ratio38.52 Forward P/E Ratio39.56 P/E Growth4.3Net Income$276.80 million Net Margins13.22% Pretax MarginN/A Return on Equity13.24% Return on Assets7.55% Debt Debt-to-Equity Ratio7.16 Current Ratio3.40 Quick Ratio2.47 Sales & Book Value Annual Sales$2.09 billion Price / Sales5.11 Cash Flow€0.09 per share Price / Cash Flow1,398.28 Book Value€24.14 per share Price / Book4.95Miscellaneous Outstanding Shares89,440,000Free FloatN/AMarket Cap$10.68 billion OptionableNot Optionable Beta0.92 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Markus WeberCEO & Chairman of Management BoardMr. Justus Felix Wehmer (Age 59)CFO & Member of the Management Board Comp: $609.4kDr. Christian Munster (Age 53)Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board Stefanie SpanagelChief Operating OfficerMr. Sebastian FrericksDirector of Investor RelationsEva-Maria HeineChief Human Resources OfficerMr. Steven C. Schallhorn M.D.Chief Medical Officer for Global Ophthalmic DevicesMr. Andrew ChangHead of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc.Dr. Euan S. Thomson Ph.D. (Age 61)President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit Mr. Magnus ReibenspiessHead of the Microsurgery Strategic Business Unit - ZEISS Medical TechnologyMore ExecutivesKey CompetitorsSartorius AktiengesellschaftETR:SRTGerresheimerETR:GXIFresenius Medical CareETR:FMEMerck KGaAETR:MRKBayer AktiengesellschaftETR:BAYNView All Competitors AFX Stock Analysis - Frequently Asked Questions What is Carl Zeiss Meditec's stock price target for 2024? 0 analysts have issued 12-month target prices for Carl Zeiss Meditec's stock. Their AFX share price targets range from €175.00 to €175.00. On average, they anticipate the company's share price to reach €175.00 in the next twelve months. This suggests a possible upside of 51.1% from the stock's current price. View analysts price targets for AFX or view top-rated stocks among Wall Street analysts. How have AFX shares performed in 2024? Carl Zeiss Meditec's stock was trading at €98.84 at the beginning of the year. Since then, AFX stock has increased by 17.2% and is now trading at €115.80. View the best growth stocks for 2024 here. Is Carl Zeiss Meditec a good dividend stock? Carl Zeiss Meditec (ETR:AFX) pays an annual dividend of €1.10 per share and currently has a dividend yield of 0.94%. The dividend payout ratio is 35.48%. This payout ratio is at a healthy, sustainable level, below 75%. What other stocks do shareholders of Carl Zeiss Meditec own? Based on aggregate information from My MarketBeat watchlists, some companies that other Carl Zeiss Meditec investors own include Covestro (1COV), AbbVie (ABBV), Allianz (ALV), Daimler (DAI), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM) and SAP (SAP). This page (ETR:AFX) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchAI healthcare stock poised for 36,996% growth?Behind the MarketsMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carl Zeiss Meditec AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.